As a result of univariate analysis, MYC targets V1 and V2 had a greater impact on sarcoma patient survival than the G2M checkpoint, E2F targets, glycolysis, unfolded protein response, mtorc1 signaling, cholesterol homeostasis, mitotic spindle and other cancer hallmarks (Figure 2A). This evidence concerns the gene MYC and sarcoma.